查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1586130

心血管吻合装置市场：依产品类型、应用分类 - 全球预测 2025-2030

Cardiovascular Anastomosis Devices Market by Product Type (Automatic, Manual), End-Use (Ambulatory Surgical Centers, Hospitals, Specialty Clinics) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年心血管吻合器械市场价值为17.9亿美元，预计到2024年将达到19.7亿美元，复合年增长率为10.63%，预计到2030年将达到36.3亿美元。

心血管吻合器是外科手术中连结血管、促进血流、促进癒合的重要工具。这些仪器对于血管成形术、搭桥手术和器官移植等手术至关重要。由于人口老化、久坐的生活方式和不健康的饮食，全球心血管疾病的盛行率不断增加，因此对这些设备的需求越来越大。其应用涵盖大量最终用户，包括医院、专科诊所和门诊手术中心，反映出进行心血管手术的地点广泛。市场成长主要是由微创手术需求的增加、吻合装置的技术进步以及政府的支持政策所推动的。主要商机位于新兴市场，这些市场的医疗保健支出不断增加，对先进医疗保健基础设施的需求尚未满足。为了利用这些机会，公司应该透过研究和开发来扩大产品系列，并专注于满足这些地区需求的经济高效的设备。然而，严格的监管核准、手术高成本以及手术期间潜在的併发症等挑战可能会阻碍市场成长。生物可吸收设备的开发、吻合过程的自动化以及人工智慧的整合等领域的创新已经成熟，以提高结果的准确性和可预测性。个人化医疗也有潜力，可以客製化设备以满足个别患者的需求。市场竞争非常激烈，越来越多的新参与企业专注于利基创新，而现有公司的影响力也越来越大。透过了解这些动态并采取策略伙伴关係、研发投资以及以患者为中心的方法，公司可以克服挑战并利用心血管吻合设备市场的成长潜力。了解监管环境并与医疗保健提供者建立关係对于长期成功也至关重要。

主要市场统计
基准年[2023] 17.9亿美元
预测年份 [2024] 19.7亿美元
预测年份 [2030] 36.3亿美元
复合年增长率（%） 10.63%

市场动态：快速发展的心血管吻合装置市场的关键市场洞察

供需的动态交互作用正在改变心血管吻合装置市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 全球心臟疾病盛行率不断上升
    • 由于吸烟、烟草和酒精消费的增加，久坐的生活方式增加
    • 全球外科手术数量增加
  • 市场限制因素
    • 治疗费用高且缺乏先进的医疗基础设施
  • 市场机会
    • 心血管吻合器技术发展进展
    • 政府措施和医疗机构的潜在资金
  • 市场挑战
    • 对吻合併发症的担忧

波特五力：驾驭心血管吻合器械市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解心血管吻合器械市场的外部影响

外部宏观环境因素在塑造心血管吻合器材市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解心血管吻合器材市场竞争格局

对心血管吻合装置市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵心血管吻合装置市场供应商的绩效评估

FPNV 定位矩阵是评估心血管吻合设备市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，以规划心血管吻合器材市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对心血管吻合装置市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全世界心臟病的发生率正在增加。
      • 随着吸烟、烟草和酒精消费的增加，久坐的生活方式也增加
      • 全球手术数量不断增加
    • 抑制因素
      • 治疗费用高且缺乏先进的医疗基础设施
    • 机会
      • 心血管吻合器技术发展进展
      • 政府措施和医疗机构的潜在资金
    • 任务
      • 对吻合併发症的担忧
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章心血管吻合装置市场：依产品类型

  • 自动的
  • 手动的

第七章心血管吻合装置市场：依最终用途

  • 门诊手术中心
  • 医院
  • 专科诊所

第八章北美和南美心血管吻合器材市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太心血管吻合器材市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲心血管吻合器材市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Applied Medical Resources Corporation
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Biosintex
  • Boston Scientific Corporation
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Getinge AB
  • Intuitive Surgical, Inc.
  • Johnson & Johnson Services, Inc.
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd.
  • Peters Surgical
Product Code: MRR-8C74ADFBF9A7

The Cardiovascular Anastomosis Devices Market was valued at USD 1.79 billion in 2023, expected to reach USD 1.97 billion in 2024, and is projected to grow at a CAGR of 10.63%, to USD 3.63 billion by 2030.

Cardiovascular anastomosis devices are critical tools used in surgical procedures to join blood vessels, facilitating blood flow and promoting healing. These devices are integral in procedures such as angioplasty, bypass surgeries, and organ transplantation. The necessity of these devices stems from the rising prevalence of cardiovascular diseases globally, driven by aging populations, sedentary lifestyles, and unhealthy diets. Their application spans numerous end-users including hospitals, specialty clinics, and ambulatory surgical centers, reflecting the broad scope of where cardiovascular surgeries are performed. Market growth is significantly influenced by the increasing demand for minimally invasive surgical procedures, technological advancements in anastomosis devices, and supportive government policies. Key opportunities lie in emerging markets with increasing healthcare expenditure and the unmet need for advanced healthcare infrastructure. To capitalize on these opportunities, companies should focus on expanding product portfolios through research and development, emphasizing cost-effective and efficient devices that cater to these regions. However, challenges such as stringent regulatory approvals, high cost of surgical procedures, and potential complications during surgeries may hinder market growth. Innovation is ripe in areas like the development of bioresorbable devices, automation in anastomosis processes, and integration of AI for enhanced precision and outcome predictability. There's also potential in personalized medicine, where device customization can cater to individual patient needs. The market is competitive with a significant presence of established players, alongside growing participation from new entrants focusing on niche innovations. By understanding these dynamics and focusing on strategic partnerships, investments in R&D, and adopting a patient-centric approach, companies can navigate the challenges and harness the growth potentials of the cardiovascular anastomosis devices market. Understanding the regulatory landscape and fostering relationships with healthcare providers are also vital for long-term success.

KEY MARKET STATISTICS
Base Year [2023] USD 1.79 billion
Estimated Year [2024] USD 1.97 billion
Forecast Year [2030] USD 3.63 billion
CAGR (%) 10.63%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiovascular Anastomosis Devices Market

The Cardiovascular Anastomosis Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of cardiac diseases globally
    • Rising sedentary lifestyle along with increasing smoking, tobacco, and alcohol consumption
    • Growing number of surgical procedures globally
  • Market Restraints
    • Highly expensive treatments and lack of advanced healthcare infrastructure
  • Market Opportunities
    • Advancements in technological developments in the cardiovascular anastomosis devices
    • Government initiatives and availability of funding for healthcare facilities
  • Market Challenges
    • Concerns related to anastomosis complications

Porter's Five Forces: A Strategic Tool for Navigating the Cardiovascular Anastomosis Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiovascular Anastomosis Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiovascular Anastomosis Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiovascular Anastomosis Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiovascular Anastomosis Devices Market

A detailed market share analysis in the Cardiovascular Anastomosis Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiovascular Anastomosis Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiovascular Anastomosis Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiovascular Anastomosis Devices Market

A strategic analysis of the Cardiovascular Anastomosis Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiovascular Anastomosis Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Applied Medical Resources Corporation, B. Braun Melsungen AG, Baxter International, Inc., Becton, Dickinson and Company, Biosintex, Boston Scientific Corporation, CryoLife, Inc., Edwards Lifesciences Corporation, Getinge AB, Intuitive Surgical, Inc., Johnson & Johnson Services, Inc., Medtronic PLC, Meril Life Sciences Pvt. Ltd., and Peters Surgical.

Market Segmentation & Coverage

This research report categorizes the Cardiovascular Anastomosis Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Automatic and Manual.
  • Based on End-Use, market is studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of cardiac diseases globally
      • 5.1.1.2. Rising sedentary lifestyle along with increasing smoking, tobacco, and alcohol consumption
      • 5.1.1.3. Growing number of surgical procedures globally
    • 5.1.2. Restraints
      • 5.1.2.1. Highly expensive treatments and lack of advanced healthcare infrastructure
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in technological developments in the cardiovascular anastomosis devices
      • 5.1.3.2. Government initiatives and availability of funding for healthcare facilities
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns related to anastomosis complications
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cardiovascular Anastomosis Devices Market, by Product Type

  • 6.1. Introduction
  • 6.2. Automatic
  • 6.3. Manual

7. Cardiovascular Anastomosis Devices Market, by End-Use

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Hospitals
  • 7.4. Specialty Clinics

8. Americas Cardiovascular Anastomosis Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Cardiovascular Anastomosis Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Cardiovascular Anastomosis Devices Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Applied Medical Resources Corporation
  • 3. B. Braun Melsungen AG
  • 4. Baxter International, Inc.
  • 5. Becton, Dickinson and Company
  • 6. Biosintex
  • 7. Boston Scientific Corporation
  • 8. CryoLife, Inc.
  • 9. Edwards Lifesciences Corporation
  • 10. Getinge AB
  • 11. Intuitive Surgical, Inc.
  • 12. Johnson & Johnson Services, Inc.
  • 13. Medtronic PLC
  • 14. Meril Life Sciences Pvt. Ltd.
  • 15. Peters Surgical

LIST OF FIGURES

  • FIGURE 1. CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY AUTOMATIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY MANUAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. CARDIOVASCULAR ANASTOMOSIS DEVICES MARKET, FPNV POSITIONING MATRIX, 2023